John R. Stuelpnagel, Director at 10x Genomics, Inc. (TXG), sold 5,000 shares at $150.51 ($753K) on 2021-10-18, disclosed to the SEC on 2021-10-20.
Open-market sale of $753k TXG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.51 | 4,400 | $662K | 87.9% |
| 2 | $151.41 | 300 | $45K | 6.0% |
| 3 | $152.20 | 300 | $46K | 6.1% |
| Total | $150.67 avg | 5,000 | $753K | 100% |
| Filing → |
| TXG | SELL | 2023-06-07 | $549K | — | Filing → |
| TXG | SELL | 2022-01-04 | $1.5M | — | Filing → |
| TXG | SELL | 2021-12-03 | $756K | — | Filing → |